O'Neil; Karyn T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for O'Neil; Karyn T..The latest application filed is for "engineered anti-il-13 antibodies, compositions, methods and uses".

Company Profile

0.7.9

O'Neil; Karyn T. - Radnor PA
O'Neil; Karyn T. - Media PA
O'Neil; Karyn T. - Kennett Square PA
O'Neil; Karyn T. - Kennatt Square PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Engineered anti-IL-13 antibodies, compositions, methods and uses Grant 8,399,630 - Swanson , et al. March 19, 2	2013-03-19
Engineered anti-IL-13 antibodies, compositions, methods and uses Grant 8,323,646 - Swanson , et al. December 4, 2	2012-12-04
Engineered Anti-il-13 Antibodies, Compositions, Methods And Uses App 20120045438 - Swanson; Ronald V. ; et al.	2012-02-23
Pharmaceutical composition comprising a human GLP-1 mimetibody Grant 8,071,103 - O'Neil , et al. December 6, 2	2011-12-06
Method for treating insulin sensitivity by long-acting GLP-1 receptor mimetibody agonists Grant 7,833,531 - O'Neil , et al. November 16, 2	2010-11-16
Human immunodeficiency virus gp41 mimetibody polypeptides Grant 7,744,897 - Dillon , et al. June 29, 2	2010-06-29
Engineered Anti-il-13 Antibodies, Compositions, Methods And Uses App 20100111959 - Swanson; Ronald V. ; et al.	2010-05-06
Human Glp-1 Mimetibodies, Compositions, Methods And Uses App 20090325873 - O'Neil; Karyn T. ; et al.	2009-12-31
Use Of Long-acting Glp-1 Receptor Agonists To Improve Insulin Sensitivity And Lipid Profiles App 20090098108 - O'Neil; Karyn T. ; et al.	2009-04-16
Human Glp-1 Mimetibodies, Compositions, Methods And Uses App 20080044411 - O'NEIL; Karyn T. ; et al.	2008-02-21
Anti-IL-13 antibodies, compositions, methods and uses App 20080044420 - Heavner; George A. ; et al.	2008-02-21
GLP-1 agonists, compositions, methods and uses App 20070128193 - O'Neil; Karyn T. ; et al.	2007-06-07
Anti-retroviral agents, compositions, methods and uses App 20050136061 - Dillon, Susan B. ; et al.	2005-06-23
Detection of patients at risk for developing integrin antagonist/agonist mediated disease states Grant 6,623,981 - Billheimer , et al. September 23, 2	2003-09-23
Detection Of Patients At Risk For Developing Integrin Antagonist/ Agonist Mediated Disease States App 20020081624 - BILLHEIMER, JEFFREY T. ; et al.	2002-06-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.